This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Sutro Biopharma, Inc.. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Miao Wen: Innovator in Antibody Conjugates
Introduction
Miao Wen is a prominent inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 2 patents, his work focuses on innovative therapeutic solutions.
Latest Patents
Miao Wen's latest patents include "Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates." These patents relate to antibodies and antibody conjugates that specifically bind to receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs. The disclosed compositions include pharmaceutical formulations and methods for producing and utilizing these antibodies in therapeutic and diagnostic applications.
Career Highlights
Miao Wen is currently associated with Sutro Biopharma, Inc., where he continues to advance his research in antibody drug conjugates. His work is pivotal in developing new treatments that leverage the specificity of these antibodies for targeted therapies.
Collaborations
Miao collaborates with talented coworkers, including Amandeep Gakhal and Abigail Yu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Miao Wen's contributions to the field of antibody conjugates exemplify the impact of innovative research in biotechnology. His patents and ongoing work at Sutro Biopharma, Inc. highlight the potential for advancements in therapeutic applications.